Spangler J G, Kirk J K, Knudson M P
Department of Family and Community Medicine, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC 27157-1084.
J Fam Pract. 1994 Feb;38(2):186-91.
Acyclovir, an antiviral nucleoside analogue, is a widely used agent highly specific for herpes simplex and varicella-zoster viruses. Unintended exposure to acyclovir early in pregnancy, which is not uncommon, may cause excessive maternal and physician anxiety. This drug has not been studied prospectively in large numbers of pregnant women and lacks the Food and Drug Administration's approval for gestational use unless benefits clearly outweigh potential fetal harm. However, data published since acyclovir became available do not indicate increased adverse effects related to its use in pregnancy, especially if prescribed in selected situations, such as disseminated primary herpes simplex infections or maternal varicella pneumonia. This article reports the impact of inadvertent acyclovir exposure on a woman during the first trimester of pregnancy and reviews the literature on acyclovir's pharmacology, safety profile, and potential uses during pregnancy.
阿昔洛韦是一种抗病毒核苷类似物,是一种广泛使用的药物,对单纯疱疹病毒和水痘-带状疱疹病毒具有高度特异性。孕期早期意外接触阿昔洛韦的情况并不少见,这可能会引起孕妇和医生不必要的焦虑。该药物尚未在大量孕妇中进行前瞻性研究,并且未获得美国食品药品监督管理局(FDA)对孕期使用的批准,除非其益处明显超过对胎儿的潜在危害。然而,自阿昔洛韦上市以来发表的数据并未表明孕期使用该药物会增加不良反应,特别是在特定情况下(如播散性原发性单纯疱疹感染或孕妇水痘肺炎)开具处方时。本文报告了一名孕妇在孕早期意外接触阿昔洛韦的影响,并综述了有关阿昔洛韦药理学、安全性概况及其在孕期潜在用途的文献。